Teleflex (NYSE:TFX) Rating Increased to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Teleflex (NYSE:TFX) from a sell rating to a hold rating in a research report sent to investors on Sunday morning.

Several other analysts also recently weighed in on the stock. Bank of America raised shares of Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 target price on the stock in a report on Monday, April 13th. Raymond James Financial reissued an “outperform” rating and set a $150.00 price target on shares of Teleflex in a report on Friday, May 8th. Mizuho raised their price objective on shares of Teleflex from $140.00 to $145.00 and gave the company a “neutral” rating in a research report on Wednesday, July 15th. Zacks Research raised Teleflex from a “strong sell” rating to a “hold” rating in a report on Tuesday, April 28th. Finally, Wells Fargo & Company boosted their target price on Teleflex from $130.00 to $138.00 and gave the stock an “equal weight” rating in a research report on Friday, May 8th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $149.80.

Teleflex Price Performance

Teleflex stock opened at $134.50 on Friday. Teleflex has a 12 month low of $100.18 and a 12 month high of $145.00. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.60 and a quick ratio of 2.12. The business has a 50 day simple moving average of $131.72 and a 200-day simple moving average of $122.68. The stock has a market capitalization of $5.95 billion, a PE ratio of -5.78, a price-to-earnings-growth ratio of 0.90 and a beta of 0.81.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, August 6th. The medical technology company reported $1.76 earnings per share for the quarter, beating analysts’ consensus estimates of $1.28 by $0.48. The firm had revenue of $570.33 million for the quarter, compared to analyst estimates of $559.59 million. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. Teleflex’s quarterly revenue was up 28.9% on a year-over-year basis. During the same period last year, the firm posted $3.73 EPS. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. Equities analysts predict that Teleflex will post 7.44 earnings per share for the current year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Friday, August 14th will be given a $0.34 dividend. The ex-dividend date is Friday, August 14th. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. Teleflex’s payout ratio is currently -5.84%.

Hedge Funds Weigh In On Teleflex

Several hedge funds have recently added to or reduced their stakes in the business. Pzena Investment Management LLC acquired a new position in Teleflex during the second quarter worth about $76,462,000. BlackRock Inc. acquired a new stake in shares of Teleflex in the second quarter valued at approximately $688,537,000. Deutsche Bank AG purchased a new position in shares of Teleflex during the 2nd quarter worth approximately $6,106,000. Rice Hall James & Associates LLC purchased a new position in shares of Teleflex during the 2nd quarter worth approximately $578,000. Finally, Trust Co. of Vermont acquired a new position in shares of Teleflex during the 2nd quarter worth approximately $57,000. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

More Teleflex News

Here are the key news stories impacting Teleflex this week:

• Positive Sentiment: Teleflex announced a $250 million accelerated share repurchase agreement. The program should reduce the company’s share count and may support per-share earnings and investor sentiment. Teleflex Launches $250 Million Accelerated Share Repurchase
• Positive Sentiment: Second-quarter revenue rose 28.9% year over year to $570.3 million, exceeding the $559.6 million consensus estimate. Adjusted EPS of $1.76 also beat expectations of $1.28, providing evidence of better-than-expected operating performance. Teleflex Surpasses Q2 Earnings and Revenue Estimates
• Positive Sentiment: Teleflex raised or reaffirmed its fiscal 2026 adjusted EPS outlook at $6.90 to $7.20, above the $6.70 analyst consensus. Piper Sandler maintained an Overweight rating and increased its price target to $169 from $160, signaling additional potential upside. Piper Sandler Rating and Price Target
• Neutral Sentiment: Teleflex declared a quarterly dividend of $0.34 per share, payable September 30 to shareholders of record August 14. The dividend provides ongoing shareholder returns, though its approximately 1% yield is unlikely to be a major short-term catalyst.
• Negative Sentiment: GAAP diluted EPS from continuing operations fell to $0.96 from $1.54 a year earlier, while adjusted EPS declined from $3.73. Teleflex also reported a negative net margin, which may be weighing on the stock despite the quarterly earnings beat. Teleflex Reports Second Quarter Financial Results and Full Year 2026 Outlook

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.